European Technology Platform Nanomedicine

Last updated

The European Technology Platform on Nanomedicine (ETP Nanomedicine) is a European Technology Platform initiative to improve the competitive situation of the European Union in the field of nanomedicine, the application of nanotechnology to medicine.

Contents

Overview

An important initiative, led by industry, has been set up together with the European Commission. A group of 53 European stakeholders, composed of industrial and academic experts, has established a European Technology Platform on nanomedicine. The first task of this high level group was to write a vision document for this highly future-oriented area of nanotechnology-based healthcare in which experts describe an extrapolation of needs and possibilities until 2020. Beginning of 2006 this Platform has been opened to a wider participation (December 2006: 150 member organisations) and has delivered a so-called Strategic Research Agenda showing a well elaborated common European way of working together for the healthcare of the future trying to match the high expectations that nanomedicine has raised so far.

Policy Objectives

Topics

Three key priorities have been confirmed by the stakeholders:

Dissemination of knowledge, regulatory and IPR issues, standardisation, ethical, safety, environmental and toxicity concerns as well as public perception in general and the input from other stakeholders like insurance companies or patient organisations play an important role.

See also

Related Research Articles

Nanomedicine is the medical application of nanotechnology. Nanomedicine ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines. Current problems for nanomedicine involve understanding the issues related to toxicity and environmental impact of nanoscale materials.

<span class="mw-page-title-main">Nanorobotics</span> Emerging technology field

Nanoid robotics, or for short, nanorobotics or nanobotics, is an emerging technology field creating machines or robots whose components are at or near the scale of a nanometer. More specifically, nanorobotics refers to the nanotechnology engineering discipline of designing and building nanorobots with devices ranging in size from 0.1 to 10 micrometres and constructed of nanoscale or molecular components. The terms nanobot, nanoid, nanite, nanomachine and nanomite have also been used to describe such devices currently under research and development.

The  International Pharmaceutical Federation or  Fédération Internationale Pharmaceutique, abbreviated as  FIP, is a nongovernmental organization (NGO) in official relations with the World Health Organization. It is the global body representing over four million pharmacists, pharmaceutical scientists and pharmaceutical educators through 153 national organisations, academic institutional members and individual members.

<span class="mw-page-title-main">European Research Area</span> System of scientific research programs in the EU

The European Research Area (ERA) is a system of scientific research programs integrating the scientific resources of the European Union (EU). Since its inception in 2000, the structure has been concentrated on European cooperation in the fields of medical, environmental, industrial, and socioeconomic research. The ERA can be likened to a research and innovation equivalent of the European "common market" for goods and services. Its purpose is to increase the competitiveness of European research institutions by bringing them together and encouraging a more inclusive way of work, similar to what already exists among institutions in North America and Japan. Increased mobility of knowledge workers and deepened multilateral cooperation among research institutions among the member states of the European Union are central goals of the ERA.

The European Institute of Innovation and Technology (EIT) is an independent body of the European Union with juridical personality, established in 2008 intended to strengthen Europe's ability to innovate. The EIT’s three “core pillars” of activities are: entrepreneurial education programmes and courses across Europe that transform students into entrepreneurs; business creation and acceleration services that scale ideas and budding businesses; and innovation-driven research projects that turn ideas into products by connecting partners, investors, and expertise.

The impact of nanotechnology extends from its medical, ethical, mental, legal and environmental applications, to fields such as engineering, biology, chemistry, computing, materials science, and communications.

<span class="mw-page-title-main">European Federation of Pharmaceutical Industries and Associations</span>

The European Federation of Pharmaceutical Industries and Associations (EFPIA) is a Brussels-based trade association and lobbying organisation, founded in 1978 and representing the research-based pharmaceutical industry operating in Europe. Through its membership of 37 national associations and 38 leading pharmaceutical companies, EFPIA represents 1,900 European companies in the areas of researching, developing and manufacturing new medical treatments.

<span class="mw-page-title-main">European Institute for Health Records</span>

The European Institute for Health Records or EuroRec Institute is a non-profit organization founded in 2002 as part of the ProRec initiative. On 13 May 2003, the institute was established as a non-profit organization under French law. Current President of EuroRec is Prof. Dipak Kalra. The institute is involved in the promotion of high quality Electronic Health Record systems in the European Union. One of the main missions of the institute is to support, as the European authorised certification body, EHRs certification development, testing and assessment by defining functional and other criteria.

<span class="mw-page-title-main">Nanoscopic scale</span> Structures with a length scale applicable to nanotechnology

The nanoscopic scale usually refers to structures with a length scale applicable to nanotechnology, usually cited as 1–100 nanometers (nm). A nanometer is a billionth of a meter. The nanoscopic scale is a lower bound to the mesoscopic scale for most solids.

The Integral SatCom Initiative (ISI) was an Information and Communications Technologies (ICT) European Technology Platform (ETP) led by the European SatCom industry and supported by the European Commission to address Satellite Communications (SatCom) strategic research and innovation challenges. It gathered approximately 200 member organisations representing all the stakeholders of the European SatCom sector from 29 different countries. It included members from manufacturing industry, network operations and service provision, SMEs, research centres and academia, European and National Institutions. Some international research entities do also participate. In 2013, after a public call by the European Commission to re-structure ETPs to better fit Horizon 2020 interests, ISI formally merged with Net!Works ETP to form NetWorld ETP, bringing together almost 1,000 partner organisations. NetWorld would become the partner ETP in the contractual public-private innovation partnership on 5G Infrastructures with the EU in December 2013.

The European Photonics Industry Consortium (EPIC) is a not-for-profit association with headquarters in Paris, France. EPIC serves the photonics community through a regular series of workshops, market studies and partnering. EPIC focuses its actions on LEDs and OLEDs for lighting, optical fiber telecommunications, laser manufacturing, sensors, photovoltaics and photonics for life sciences. EPIC coordinates its activities internationally through its membership in the International Optoelectronics Association.

The Office of the National Coordinator for Health Information Technology (ONC) is a staff division of the Office of the Secretary, within the U.S. Department of Health and Human Services. ONC leads national health IT efforts, charged as the principal federal entity to coordinate nationwide efforts to implement and use the most advanced health information technology and the electronic exchange of health information.

<span class="mw-page-title-main">Nigeria Vision 2020</span>

Nigeria Vision 2020 is a strategic framework for the Federal Republic of Nigeria to develop its economic and political strength to the point by 2020, “Nigeria will be one of the 20 largest economies in the world, able to consolidate its leadership role in Africa and establish itself as a significant player in the global economic and political arena.”

<span class="mw-page-title-main">Euroregion Baltic</span>

The Euroregion Baltic (ERB) refers to a cross-border Euroregion in the south-east of the Baltic Sea Region, consisting of eight regions of Denmark, Lithuania, Poland, Russia, and Sweden. On 2 March 2022, the ERB's Executive Board suspended Russia's membership, in response to Russia's invasion of Ukraine.

Informatics for Consumer Health (ICH) is a government initiative coordinated by the National Cancer Institute (NCI) within the National Institutes of Health (NIH). ICH focuses on a coordination of health information, technology, and health care delivery that empowers providers to manage care and increases the ability of consumers to gain mastery over their own health. The ICH online initiative involved stakeholders from various sectors—commercial IT, government, health care, education, research, and advocacy—exchanging ideas and resources to bridge information technology and health care with the goal of improving behavioral support for all consumers. The Informatics for Consumer Health field is related to health informatics, medical informatics, consumer health informatics, eHealth, and health information technology.

The European Marine Board is a pan-European network of national organizations involved in marine research which are either research funding organizations, research performing organizations, or nationally based consortia of third-level institutes. The European Marine Board (EMB) is the leading European think tank in marine science policy. The Board provides a platform for its member organizations to develop common priorities, to advance marine research, and to bridge the gap between science and policy to meet future marine science challenges and opportunities. Established in 1995, it is a partnership facilitating enhanced cooperation between European organizations involved in marine science towards development of a common vision on the research priorities and strategies for marine science in Europe. It also facilitates enhanced cooperation between stakeholders involved in supporting, delivering and using marine research and technology.

The International Institute for Nanotechnology (IIN) was established by Northwestern University in 2000. It was the first institute of its kind in the United States and is one of the premier nanoscience research centers in the world. Today, the IIN represents and unites more than $1 billion in nanotechnology research, educational programs, and supporting infrastructure.

<span class="mw-page-title-main">Institute for Bioengineering of Catalonia</span>

The Institute for Bioengineering of Catalonia (IBEC) is an institution engaged in basic and applied research in bioengineering and nanomedicine, with experts working on tissue regeneration, biomechanics, molecular dynamics, biomimetics, drug delivery, organs ‘on-a-chip’, cell migration, stem cells, artificial olfaction and microbial biotechnology. The institute was created by the Government of Catalonia, the University of Barcelona and the Polytechnic University of Catalonia in December 2005 and is located at the Barcelona Science Park. The director of the institute is Prof. Josep Samitier, who took over from founding director Josep A. Planell i Estany in 2013. In 2014 IBEC was named a "Severo Ochoa Centre of Excellence" by the Spanish Ministry of Economy and Competitiveness.

The European Federation of Organisations for Medical Physics (EFOMP) was founded in May 1980 in London to serve as an umbrella organisation representing the national Medical Physics societies in Europe. The office moved to Utrecht in January 2021. It is a non-profit organisation and aims to foster and coordinate the activities of its national member organisations, encourage exchange and dissemination of professional and scientific information, develop guidelines for education, training and accreditation programmes and to make recommendations on the responsibilities, organisational relationships and roles of medical physicists.

References